{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:38:17Z","timestamp":1790980697764,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/bf03032652","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T19:36:53Z","timestamp":1254080213000},"page":"10-17","source":"Crossref","is-referenced-by-count":24,"title":["Phenotypic alterations in Kaposi\u2019s sarcoma cells by antisense reduction of perlecan"],"prefix":"10.1007","volume":"6","author":[{"given":"Chiara","family":"Marchisone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Del Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Masiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03032652_CR1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1023\/A:1008243115385","volume":"8","author":"R Adatia","year":"1997","unstructured":"Adatia R, Albini A, Giunciuglio D, et al: Suppression of invasive behaviour of melanoma cells by stable expression of antisense perlecan cDNA. Annals Oncology 8:1257\u20131261, 1997.","journal-title":"Annals Oncology"},{"key":"BF03032652_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02905254","volume":"4","author":"A Albini","year":"1998","unstructured":"Albini A: Tumor and endothelial cell invasion of basement membranes. Pathology Oncology Res. 4:1\u201312, 1998.","journal-title":"Pathology Oncology Res."},{"key":"BF03032652_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00002030-199706000-00003","volume":"11","author":"A Albini","year":"1997","unstructured":"Albini A, Paglieri I, Orengo G, et al: The \u03b2-core fragment of human Chorionic Gonadotropin (hCG) inhibits growth of Kaposi\u2019s sarcoma-derived cells and a new immortalized Kaposi\u2019s sarcoma cell line. AIDS 11:713\u2013721, 1997.","journal-title":"AIDS"},{"key":"BF03032652_CR4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/15537","volume":"23","author":"E Arikawa-Hirasawa","year":"1999","unstructured":"Arikawa-Hirasawa E, Watanabe H, Takami H, et al: Perlecan is essential for cartilage and cephalic development. Nat Genet 23:354\u2013358, 1999.","journal-title":"Nat Genet"},{"key":"BF03032652_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-230X(08)60279-1","volume":"53","author":"J Armes","year":"1989","unstructured":"Armes J: A review of Kaposi\u2019s sarcoma. Advan. Cancer Res. 53:73\u201387, 1989.","journal-title":"Advan. Cancer Res."},{"key":"BF03032652_CR6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0092-8674(94)90031-0","volume":"79","author":"D Aviezer","year":"1994","unstructured":"Aviezer D, Hecht D, Safran M, et al: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79:1005\u20131013, 1994.","journal-title":"Cell"},{"key":"BF03032652_CR7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/MCB.17.4.1938","volume":"17","author":"D Aviezer","year":"1997","unstructured":"Aviezer D, Iozzo RV, Noonan DM, et al: Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol. Cell Biol. 17:1938\u20131946, 1997.","journal-title":"Mol. Cell Biol."},{"key":"BF03032652_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0021-9258(17)42321-0","volume":"269","author":"D Aviezer","year":"1994","unstructured":"Aviezer D, Levy E, Safran M, et al: Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269:114\u2013121, 1994.","journal-title":"J Biol Chem"},{"key":"BF03032652_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi, N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156\u2013159, 1987.","journal-title":"Anal. Biochem."},{"key":"BF03032652_CR10","first-page":"1851","volume":"149","author":"E Cornali","year":"1996","unstructured":"Cornali E, Zietz C, Benelli R, et al: Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi\u2019s sarcoma. Am J Path 149:1851\u20131869, 1996.","journal-title":"Am J Path"},{"key":"BF03032652_CR11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.147.5.1109","volume":"147","author":"M Costell","year":"1999","unstructured":"Costell M, Gustafsson E, Aszodi A, et al: Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109\u20131122, 1999.","journal-title":"J Cell Biol"},{"key":"BF03032652_CR12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/371674a0","volume":"371","author":"B Ensoli","year":"1994","unstructured":"Ensoli B, Gendelman R, Markham P, et al: Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi\u2019s sarcoma. Nature 371:674\u2013680, 1994.","journal-title":"Nature"},{"key":"BF03032652_CR13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s001099900019","volume":"77","author":"N Ferrara","year":"1999","unstructured":"Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527\u2013543, 1999.","journal-title":"J Mol Med"},{"key":"BF03032652_CR14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/29093","volume":"394","author":"O Flore","year":"1998","unstructured":"Flore O, Rafii S, Ely S, et al: Transformation of primary human endothelial cells by Kaposi\u2019s sarcomaassociated herpesvirus. Nature 394:588\u201392, 1998.","journal-title":"Nature"},{"key":"BF03032652_CR15","first-page":"1998","volume":"55-57","author":"RC Gallo","year":"1998","unstructured":"Gallo RC: Some aspects of the pathogenesis of HIV-1-associated Kaposi\u2019s sarcoma. J Natl Cancer Inst Monogr 1998:55-57, 1998.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"BF03032652_CR16","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1073\/pnas.84.14.4831","volume":"84","author":"P Gunning","year":"1987","unstructured":"Gunning P, Leavitt J, Muscat G, et al: A human b-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84:4831\u20134835, 1987.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03032652_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07853899608999076","volume":"28","author":"P Inki","year":"1996","unstructured":"Inki P, Jalkanen M: The role of syndecan-1 in malignancies. Ann Med 28:63\u201367, 1996.","journal-title":"Ann Med"},{"key":"BF03032652_CR18","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1242\/dev.122.11.3443","volume":"122","author":"SJ Joseph","year":"1996","unstructured":"Joseph SJ, Ford MD, Barth C, et al: A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. Development 122:3443\u20133452, 1996.","journal-title":"Development"},{"key":"BF03032652_CR19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.60.070191.002303","volume":"60","author":"L Kjellen","year":"1991","unstructured":"Kjellen L, Lindahl, U: Proteoglycans: structures and interactions. Annu Rev Biochem 60:443\u2013475, 1991.","journal-title":"Annu Rev Biochem"},{"key":"BF03032652_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<168::AID-IJC7>3.0.CO;2-X","volume":"65","author":"JAM Maler","year":"1996","unstructured":"Maler JAM, Mariotti M, Albini A, et al: Over-expression of Hepatocyte Growth Factor in human Kaposi\u2019s Sarcoma. Int J Cancer 65:168\u2013172, 1996.","journal-title":"Int J Cancer"},{"key":"BF03032652_CR21","doi-asserted-by":"crossref","first-page":"24215","DOI":"10.1016\/S0021-9258(20)80513-4","volume":"268","author":"M Mali","year":"1993","unstructured":"Mali M, Elenius K, Miettinen HM, et al: Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1. J Biol Chem 268:24215\u201324222, 1993.","journal-title":"J Biol Chem"},{"key":"BF03032652_CR22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.94.3.979","volume":"94","author":"R Masood","year":"1997","unstructured":"Masood R, Cai J, Zheng T, et al: Vascular endothelial growth factor\/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979\u2013984, 1997.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03032652_CR23","first-page":"2130","volume":"57","author":"M Mathiak","year":"1997","unstructured":"Mathiak M, Yenisey C, Grant DS, et al: A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res 57:2130\u20132136, 1997.","journal-title":"Cancer Res"},{"key":"BF03032652_CR24","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1073\/pnas.91.12.5281","volume":"91","author":"YM Naidu","year":"1994","unstructured":"Naidu YM, Rosen EM, Zitnick R, et al: Role of scatter factor in the pathogenesis of AIDS-related Kaposi Sarcoma. Proc Natl Acad Sci USA 91:5281\u20135285, 1994.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03032652_CR25","first-page":"82","volume":"31","author":"D Noonan","year":"1990","unstructured":"Noonan D, Albini A, Horigan E, et al: The basement membrane heparan sulfate proteoglycan: structure and expression in melanoma cells. Proceedings of the AACR 31:82, 1990.","journal-title":"Proceedings of the AACR"},{"key":"BF03032652_CR26","doi-asserted-by":"crossref","first-page":"22939","DOI":"10.1016\/S0021-9258(18)54445-8","volume":"266","author":"DM Noonan","year":"1991","unstructured":"Noonan DM, Fulle A, Valente P, et al: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor and the neural cell adhesion molecule. J Biol Chem 266:22939\u201322947, 1991.","journal-title":"J Biol Chem"},{"key":"BF03032652_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.7682010","volume":"260","author":"V Nurcombe","year":"1993","unstructured":"Nurcombe V, Ford MD, Wildschut JA, et al: Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103\u2013106, 1993.","journal-title":"Science"},{"key":"BF03032652_CR28","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1646484","volume":"252","author":"AC Rapraeger","year":"1991","unstructured":"Rapraeger AC, Krufka A, Olwin BB: Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705\u20131708, 1991.","journal-title":"Science"},{"key":"BF03032652_CR29","doi-asserted-by":"crossref","unstructured":"Sakata H, Stahl SJ, Taylor WG, et al: Heparin binding and oligomerization of hepatocyte growth factor\/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem 2729457\u20139463, 1997.","DOI":"10.1074\/jbc.272.14.9457"},{"key":"BF03032652_CR30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-230X(08)60775-7","volume":"76","author":"TF Schulz","year":"1999","unstructured":"Schulz TF: Epidemiology of Kaposi\u2019s sarcoma-associated Herpesvirus\/human Herpesvirus 8. Adv Cancer Res 76:121\u2013160, 1999.","journal-title":"Adv Cancer Res"},{"key":"BF03032652_CR31","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1172\/JCI3793","volume":"102","author":"B Sharma","year":"1998","unstructured":"Sharma B, Handler M, Eichstetter I, et al: Antisense targeting of perlecan blocks tumor growth and angiogenesis In vivo. J Clin Invest 102:1599\u2013608, 1998.","journal-title":"J Clin Invest"},{"key":"BF03032652_CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1083\/jcb.133.2.405","volume":"133","author":"R Steinfeld","year":"1996","unstructured":"Steinfeld R, Van Den Berghe H, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133:405\u2013416, 1996.","journal-title":"J Cell Biol"},{"key":"BF03032652_CR33","doi-asserted-by":"crossref","first-page":"12456","DOI":"10.1016\/S0021-9258(18)99896-0","volume":"289","author":"S Tessler","year":"1994","unstructured":"Tessler S, Rockwell P, Hicklin D, et al: Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 289:12456\u201312461, 1994.","journal-title":"J Biol Chem"},{"key":"BF03032652_CR34","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/S0021-9258(19)50108-9","volume":"267","author":"M Yanagishita","year":"1992","unstructured":"Yanagishita M, Hascall, VC: Cell surface heparan sulfate proteoglycans. J Biol Chem 267:9451\u20139454, 1992.","journal-title":"J Biol Chem"},{"key":"BF03032652_CR35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","volume":"64","author":"A Yayon","year":"1991","unstructured":"Yayon A, Klagsbrun M, Esko JD, et al: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinty receptor. Cell 64:841\u2013848, 1991.","journal-title":"Cell"},{"key":"BF03032652_CR36","first-page":"166","volume":"73","author":"FY Zhou","year":"1997","unstructured":"Zhou FY, Owens RT, Hermonen J, et al: Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans? Eur J Cell Biol 73:166\u2013174, 1997.","journal-title":"Eur J Cell Biol"}],"container-title":["Pathology Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03032652\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:26:00Z","timestamp":1633944360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03032652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["BF03032652"],"URL":"https:\/\/doi.org\/10.1007\/bf03032652","relation":{},"ISSN":["1219-4956"],"issn-type":[{"value":"1219-4956","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}